7 Mistakes People Make While Taking Weight Loss Drugs, According to Experts
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught making these semaglutide slip-ups.
Competition explodes amid weight loss drug shortage
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth companies look to tap into the fast-growing industry.
Weight-loss drug developer BioAge raises $198 mln in U.S. IPO
BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the targeted range at $18 per share, the weight-loss drug developer said on Wednesday.
A weight loss drug developer's stock soars after a $198 million IPO
Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public offering (IPO) price on Thursday.
Weight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPO
Weight-loss drug developer BioAge Labs (BIOA) on Wednesday announced the pricing of its upsized initial public offering of 11,000,000 shares of its common stock at a public offering price of $18.00 per share.
BioAge valued at $758 mln in debut as investors bet on weight-loss drug frenzy
Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer against the backdrop of surging investor enthusiasm.
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Senator Bernie Sanders grills the top executive of Novo Nordisk over high drug prices
The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
Depth of weight loss drug pipeline will support growth even as cost lowers, says StemPoint's Ross
Michelle Ross, StemPoint Capital CIO and Novo Nordisk shareholder, joins CNBC's 'Closing Bell' to discuss the criticism Novo ...
verywellhealth4d
Novo Nordisk's Experimental Oral Drug Reports 'Remarkable' Weight Loss, Early Data Shows
In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.
The Hill1d
Telehealth companies lean into weight loss drug race
The compounded GLP-1s that Noom and Hims & Hers are selling are roughly a fifth of the monthly cost of a drug like Ozempic.
Popular diabetes and weight-loss drug associated with lower opioid overdose risk
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United ...
She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.